Second messenger pathways for oxytocin and prostaglandins in human myometrium.
Phaneuf
S
S
University of Oxford, Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, U.K.
Asboth
G
G
Europe-Finner
G N
GN
Watson
S P
SP
Lopez Bernal
A
A
D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000502:physiology; D000242:Cyclic AMP / Q000378:metabolism; D015237:Dinoprost / Q000494:pharmacology*; D015232:Dinoprostone / Q000494:pharmacology*; D005260:Female; D019204:GTP-Binding Proteins / Q000378:metabolism; D006801:Humans; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism; D008954:Models, Biological; D009215:Myometrium / Q000187:drug effects / Q000502:physiology*; D010121:Oxytocin / Q000494:pharmacology*; D015290:Second Messenger Systems; D010738:Type C Phospholipases / Q000378:metabolism
D015220:Calcium Channels; D010121:Oxytocin; D015544:Inositol 1,4,5-Trisphosphate; D015237:Dinoprost; D000242:Cyclic AMP; D010738:Type C Phospholipases; D019204:GTP-Binding Proteins; D015232:Dinoprostone; D002118:Calcium